Another NIR probe, Cy-KUE-OA, specific to PSMA and cell membrane phospholipids, was developed and validated in ex vivo imaging studies, showing potential for clinical application in FGS for prostate cancer (60). This evidence concerns the gene FOLH1 and prostate carcinoma.